No Detail Found!

The need for providing pharmaceutical care in geriatrics: A case study of diagnostic errors leading to medicationr‑elated problems in a patient treatment plan

Author(s)
Amna Shah Faculty of Pharmacy, Ziauddin University,Karachi 75600,Pakistan
Atta Abbas Naqvi Department of Pharmacy, College of Clinical Pharmacy, University of Dammam, Dammam 31441, Kingdom of Saudi Arabia
Rizwan Ahmad Natural Products and Alternative Medicines, College of Clinical Pharmacy, University of Dammam, Dammam 31441, Kingdom of Saudi Arabia
Abstract
Background: Geriatric patients are more prone to suffer from medication related problems (MRPs). It may be due to comorbidity of chronic illnesses and/or number of medications prescribed to them as compared to other age groups. Illnesses are sometimes misdiagnosed or left undiagnosed due to aging. Pharmacists have the knowledge about the disease and medication therapy in geriatrics and can provide pharmaceutical care (PC) which can supplement decision making of physician, reduce MRPs and improve treatment outcomes. Introduction: This case study highlights the need to provide PC to geriatrics. A diabetic patient presented with hypoglycemia and suspected electrolyte imbalance to the emergency room (ER) and was prescribed a treatment plan which had the potential to result in MRPs. Case Presentation: An 80 years old male geriatric patient presented to ER with hypoglycemia. Past medical history revealed Type I DM and CABG. The treatment plan was more focused on resolving signs and symptoms for which no relevant laboratory and diagnostic tests were conducted. Medication therapy was prescribed to the patient on suspected diagnosis and more than one drug of the same therapeutic class was prescribed to the patient making him prone to suffer from MRPs. Conclusion: Incorporating a pharmacist driven PC can help prescribers in establishing diagnosis, selecting rational therapies for co morbidities in geriatrics. It can eliminate unnecessary drug therapy, concomitant use of similar drugs and also reduce the chances of MRPs thereby improving treatment outcomes.
Publication Details
Page(s) 87-95
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 3, Year: 2016

Request the full text from PASTIC

Keywords
medication-related problems, Geriatrics, pharmaceutical care
References
Khan MH,Abbas A .2014 .The importance of clinical pharmacists in health care system. Med Sci, 11 : 80-1.
.1993 .The Role of the Pharmacist in the Health Care System. Report of a WHO Meeting Tokyo, Japan; 31 August‑3 September, : .
Wolstenholme B .2011 .Medication‑related problems in geriatric pharmacology. Aging Well, 4 : 8.
Andreazza RS,Silveira De Castro M,Sippel Köche P,Heineck I. .2011 .Causes of drug‑related problems in the emergency room of a hospital in Southern Brazil. Gac Sanit, 25 : 501-6.
Naqvi AA,McGarry K .2014 .. , : 1-105.
Viktil KK,Blix HS,Moger TA,Reikvam A .2007 .Polypharmacy as commonly defined is an indicator of limited value in the assessment of drugr‑elated problems. Br J Clin Pharmacol, 63 : 187-95.
Vinks TH,Egberts TC,de Lange TM .2009 .Pharmacist‑based medication review reduces potential drug‑related problems in the elderly: The SMOG controlled trial. Drugs Aging, 26 : 123-33.
Fu AZ,Liu GG,Christensen DB .2004 .Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc, 52 : 1934-9.
Abbas A,Khan N. .2014 .Clinical trials involving pharmacists in Pakistan's healthcare system: A leap from paper to practice. Pharmacy, 2 : 244-7.
. .American Association for Clinical Chemistry AACC. 2016 Mar, 20 : .
DiPiro JT,Talbert RL,McGraw‑Hill Education RL .2014 .Pharmacotherapy: A Pathophysiologic Approach. , : .
Metformin . .. ID20. [Last accessed on 2016 Mar, 21 : .
Clinic Cleveland .2010 .Centre for Continuing Education. [Last accessed on 2016 Mar, 21 : .
Alsaad KO,Herzenberg AM .2007 .Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: An update. J Clin Pathol, 60 : 18-26.
Qian Y,Feldman E,Pennathur S,Kretzler M,Brosius FC .2008 .From fibrosis to sclerosis: Mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes, 57 : 1439-45.
. .‑herapy i‑na‑dultsi‑nh‑ospitala‑lgorithmposters‑. et1‑91627821. [Last accessed on 2016 Mar, 22 : .
. .choosingantihypertensive‑drug‑treatment‑2. 2016 Mar, 22 : .
.2015 .insulint‑herapy 2‑. [Last accessed on 2016 Mar, 22 : .
Spiromide . .. [Last accessed on 2016 Mar, 22 : .
Furosemide . .. 2016 Mar, 22 : 0.
. .Scottish Intercollegiate Guidelines Network SIGN. Managing Asthma in Adults; 2014. [Last accessed on 2016 Mar, 22 : .
Edema Pulmonary . .. [Last accessed on 2016 Mar, 22 : .
Kataoka H,Matsuno O .2008 .Age‑related pulmonar y crackles (rales) in asymptomatic cardiovascular patients. Ann Fam Med, 6 : 239-45.
.2013 .20 v s 3 . p d f / a t _ d o w n l o a d / f i l e . [ L a s t a c c e s s e d o n 2016 Mar 22]. /RTI%20abbreviated%20 Antibiotic%20guidance%20Aug%202013%20update%, 69 : .
.2012 .National Institute for Health and Care Excellence NICE. A n t i b i o t i c P re s c r i b i n g Fo r Re s p i r a t o r y Tr a c t Infections. Last accessed on 2016 Mar, 23 : .
Hlatky MA,Solomon MD,Shilane D,Leong TK,Brindis R,Go AS .2013 .Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol, 61 : 295-301.
.2012 .Scottish Intercollegiate Guidelines Network SIGN. Heart Disease. [Last accessed on 2016 Mar, 23 : .
Okrainec K,Platt R,Pilote L,Eisenberg MJ L .2005 .Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol, 45 : 177-84.
Abbas A .2014 .Hypertriglyceridemia: What is it and how it is managed - A review. Int J Pharmacother, 4 : 32-5.
Abbas A .2013 .The association of dyslipidemia with osteoporosis: A case report. El Med J, 1 : 3.
Ravi SP .2009 .Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. , 87 : 804.
. .‑ prevention/lipidmodification‑therapy ‑for‑preventing‑cardiovasculardisease#content=view‑node%3Anodes‑secondary ‑ prevention. [Last accessed on 2016 Mar, 24 : .
Radcliffe KA,Campbell WW .2008 .Statin myopathy. Curr Neurol Neurosci Rep, 8 : 66-72.
Torres PA,Helmstetter JA,Kaye AM,Kaye AD .2015 .Rhabdomyolysis: Pathogenesis, diagnosis, and treatment. Ochsner J, 15 : 58-69.
Athyros VG,Papageorgiou A A,Demitriadis DS,Kontopoulos AG . .Atorvastatin plus pravastatin for the. , : .
0

Citations

0

Downloads

10

Views